CRTX Research and Charts

CRTX - Cortexyme Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2022-01-27 (Delayed quote data 2025-01-02)

Last 1.88	Change ⇑ +0.01 (+0.53%)	Volume 85,143
	Open 1.88	High 1.97	Low 1.83

8EMA (Daily) 1.85	40EMA (Daily) 1.75	50EMA (Daily) 1.68	STO (Daily) 37.520	MACD Hist (Daily) -0.033
8EMA (Weekly) 1.821	40EMA (Weekly) 1.30	50EMA (Weekly) 1.33	STO (Weekly) 71.344	MACD Hist (Weekly) 0.116


Company Profile
Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.